Malignant otitis externa (MEO) is a rare but serious ear disease characterized by tissue destruction of the auricle and/or the lateral portion of the ear canal, which can lead to significant complications. The disease usually occurs in the elderly and those with a weakened immune response, such as patients with diabetes or those receiving immunosuppressive therapy. The main etiologic factors are infections caused by pseudomonas, staphylococci and other pathogens. The clinical picture includes pain, discharge from the ear, possibly the appearance of fistulas and systemic symptoms such as fever. One of the main goals of clinicians is early diagnosis and adequate treatment of this condition to reduce the risk of serious complications, including meningitis and dissemination of infection to other parts of the body.
History of the disease and interesting historical facts
Malignant otitis externa was first described in the medical literature in the 1950s, when a group of researchers noticed a link between otitis externa and diabetes in elderly patients. Interestingly, in the early years of the disease, diagnosis was made mainly based on clinical analysis, as existing imaging techniques were unable to diagnose the extent of tissue destruction. Since then, advances in medical science and technology have led to new diagnostic and treatment methods, significantly improving the prognosis of patients. Several historical sources point to the use of various topical remedies and herbs to treat otitis externa in ancient civilizations, demonstrating how people have been looking for ways to combat ear infections for centuries.
Epidemiology
According to modern data, the prevalence of malignant otitis externa is 5-10 cases per 100,000 population per year, but among elderly patients this figure increases and can reach 25 cases per 100,000. In 80% cases, the disease is observed in people over 60 years of age, and it is especially often diagnosed in diabetics. In recent decades, there has been a slight increase in the incidence, which may be due to an increase in the number of people with diabetes mellitus and other predisposing factors in the older age group.
Genetic predisposition to this disease
To date, no specific genes have been identified that are directly associated with the development of malignant otitis externa. However, there are a number of genetic factors that contribute to an increased risk of ear infections, in particular, this may be associated with mutations in genes responsible for the immune response and tissue regeneration. For example, according to some studies, defects in genes encoding components of the immune system can make a patient more susceptible to skin and soft tissue infections, which can subsequently lead to the development of malignant neoplasms.
Risk factors for the development of this disease
Risk factors for malignant otitis externa can be both physical and chemical. Physical factors include:
- Old age
- Diabetes
- Immunodeficiency states
Chemical factors that contribute to the development of the disease may include:
- Frequent use of antibiotics
- Incorrect use of ear drops
- Contact with aggressive chemicals
In addition, it is worth noting the connection between the condition of the ear canal and future infections, such as chronic inflammatory processes on the skin, which can become prerequisites for the development of malignant otitis externa.
Diagnosis of this disease
Diagnosis of malignant otitis externa is based on clinical examination and special laboratory and radiological studies. The main symptoms that the doctor pays attention to include:
- Severe ear pain
- Purulent discharge
- Swelling and redness of the skin of the ear canal
Laboratory tests may include culture of ear discharge for microbiologic analysis to detect pathogens. Radiologic tests such as computed tomography (CT) or magnetic resonance imaging (MRI) may help identify the spread of infection to adjacent structures and assess the extent of tissue destruction. The differential diagnosis includes ruling out other conditions such as acute otitis media, furunculosis of the ear canal, and osteomyelitis, which is an important step in the diagnostic process.
Treatment
Treatment of malignant otitis externa requires a comprehensive approach, which may include both conservative and surgical methods. Primary treatment is aimed at stopping the infection and relieving symptoms. Pharmacological treatment includes:
- Broad-spectrum antibiotics such as piperacillin, second-generation cephalosporins
- Anti-inflammatory drugs to reduce pain and swelling
In the case of abscesses or necrotic tissue, surgical intervention may be required to remove the affected areas. Other treatments may include local antiseptic solutions and mechanical cleaning of the ear canal from purulent discharge.
List of medications used to treat this disease
Medications used include:
- cefepime
- Piperacillin/Tazobactam
- Ciprofloxacin
- Clapromycin
- Neostigmine methylsulfate
Each of these agents is used depending on the sensitivity of the identified pathogens and the general condition of the patient.
Disease monitoring
Monitoring of the patient's condition after treatment of malignant external otitis includes regular follow-up examinations and laboratory tests aimed at assessing the dynamics of the inflammatory process. The prognosis usually depends on the timeliness of treatment and the state of the patient's immune system. Complications may occur in the form of meningitis, osteomyelitis, and damage to adjacent anatomical structures, which emphasizes the importance of early and effective therapy.
Age-related features of the disease
Malignant otitis externa is more common in older people, due to decreased immune function and the presence of comorbidities such as diabetes and hypertension. In children, this disease is less common, but can still be observed in the presence of predisposing factors such as frequent colds and other infectious diseases. At any age, early diagnosis and adequate treatment can significantly improve the prognosis and reduce the likelihood of long-term consequences.
Questions and Answers
- What are the main symptoms of malignant otitis externa? The main symptoms include severe ear pain, purulent discharge, redness and swelling of the skin of the ear canal.
- Who is at risk for developing this disease? Those at risk include the elderly, diabetics and patients with weakened immune systems.
- How is malignant otitis externa diagnosed? Diagnosis is based on clinical signs, laboratory and radiological studies.
- What is the treatment for malignant otitis externa? Treatment may include antibiotics, anti-inflammatory drugs, and in some cases surgery.
- What is the prognosis for patients with malignant otitis externa? The prognosis depends on the timeliness of treatment, but with adequate therapy it is usually successful.
